1,085 results on '"Levy, Gerhard"'
Search Results
2. The Case for Preclinical Pharmacodynamics
3. Levy G, Hayes B, “Physiochemical Basis of the Buffered Acetylsalicylic Acid Controversy New Engl. J. Med. 262:1053–1058 (1960)”—The Backstory
4. Predicting Effective Drug Concentrations for Individual Patients: Determinants of Pharmacodynamic Variability
5. Feasibility of Effect-Controlled Clinical Trials of Drugs with Pharmacodynamic Hysteresis Using Sparse Data
6. Opportunities for Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development
7. Optimization of the Therapeutic Index by Adjustment of the Rate of Drug Administration or Use of Drug Combinations: Exploratory Studies of Diuretics
8. Kinetics of Drug Action in Disease States. XXXIX. Effect of Orally Administered Activated Charcoal on the Hypnotic Activity of Phenobarbital and the Neurotoxicity of Theophylline Administered Intravenously to Rats with Renal Failure
9. Comparative pharmacokinetics of coumarin anticoagulants L: Physiologic modeling of S-warfarin in rats and pharmacologic target-mediated warfarin disposition in man
10. Developing compliance instructions for drug labeling
11. What are narrow therapeutic index drugs?
12. Significant figures or significant nonsense?
13. Pharmacokinetics at the Interface Between Pharmacology and Physiology
14. Kinetics of Drug Action in Disease States. XL. Effect of the Dialyzable Component(s) of Uremic Blood on Theophylline Neurotoxicity in Rats
15. Patient-Oriented Pharmaceutical Research: Focus on the Individual
16. Effect of Hepatic Cirrhosis on the Pharmacodynamics and Pharmacokinetics of Mivacurium in Humans1
17. A Better Way to Present Posters
18. Pharmacokinetic Assessment of the Effect of Age on the Disposition and Pharmacologic Activity of Drugs
19. Absorption, Protein Binding, and Elimination of Riboflavin
20. Variation In Rate Of Salicylate Elimination By Humans
21. Pharmacokinetic Aspects of Controlled Drug Delivery Systems
22. Comparative Pharmacokinetics of the Anticoagulant Effect of Coumarin Drugs in Man and Rat
23. A tribute to Ed Garrett
24. How Should Clinical Pharmaceutical Scientists Be Trained?
25. Gender Differences in the Pharmacodynamics of Barbiturates in Rats
26. Accumulation kinetics of drugs with nonlinear plasma protein and tissue binding characteristics
27. Effect of plasma protein and tissue binding on the time course of drug concentration in plasma
28. Pharmacokinetics of the warfarin enantiomers in rats
29. Protein binding of warfarin enantiomers in serum of humans and rats
30. Kinetics of Drug Action in Disease States. XXXI. Effect of Experimental Hyperthyroidism on the Hypnotic Activity of a Benzodiazepine (Oxazepam) in Rats
31. Pharmacodynamics of Zoxazolamine and Chlorzoxazone in Rats
32. Kinetics of Drug Action in Disease States. XXII. Effects of Contraceptive Steroids on the Pharmacodynamics of Ethanol in Rats
33. Kinetics of diphenylhydantoin elimination in rats
34. Effect of product inhibition on kinetics of drug elimination
35. Comparative pharmacokinetics of the anticoagulant effect of coumarin drugs in man and rat
36. Comparative Pharmacokinetics of the Anticoagulant Effect of Coumarin Drugs in Man and Rat
37. KINETICS AND IMPLICATIONS OF DISSOLUTION RATE. LIMITED GASTROINTESTINAL ABSORPTION OF DRUGS
38. Report of the Workshop on Controlled-Release Dosage Forms: Issues and Controversies
39. Importance of assay specificity for plasma protein binding determinations
40. Targeted Drug Delivery—Some Pharmacokinetic Considerations
41. Effect of Complex Formation on Drug Absorption
42. The Development of Pharmacodynamics as a Pharmaceutical Science: A Personal Perspective
43. Commentary: Using Other People's Data in Publications
44. Pharmacodynamic Analysis of Sparse Data from Concentration- and Effect-Controlled Clinical Trials Guided by a Pilot Study. An Investigation by Simulations
45. Population Pharmacodynamics: Strategies for Concentration- and Effect-Controlled Clinical Trials
46. The Clay Feet of Bioequivalence Testing
47. Mechanism-based pharmacodynamic modeling
48. Kinetics of Drug Action in Disease States. XLIII: Potentiating Effect of l-Tryptophan on the Hypnotic Action of Phenobarbital and Ethanol in Rats
49. Pharmacologic target-mediated drug disposition
50. Concentration- or effect-controlled clinical trials with sparse data
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.